Ervebo (rVSV-ZEBOV (Ebola vaccine))

Approved for Prevention of Ebola virus disease caused by Zaire ebolavirus in adults 18+. Live attenuated vaccine using vesicular stomatitis virus engineered to express Ebola glycoprotein, stimulating immune response. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.

Loading full data from Know Your Drugs Institute…